Sort
82,697 grants matching “vaccine development”
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$6,064,003Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2019 · AI
An Inactivated Influenza Nasal Powder Vaccine
$6,061,068Delsite Biotechnologies, Inc. · UC1 · FY2004 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$6,052,826Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2017 · AI
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$6,050,390Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2011 · AI
Therapeutics/Vaccine Teams
$6,027,830Charles Nicolette · Argos Therapeutics, Inc. · N01 · FY2011 · AI
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS
$6,026,011University Of Alabama At Birmingham · U01 · FY2001 · HD
Novel TLR7/8 agonists as adjuvants for rapid-acting vaccines
$6,018,893David Johnson · Corixa Corporation · N01 · FY2011 · AI
Adjuvant Development Program
$6,010,421Rhea Coler · Access To Advanced Health Institute · N01 · FY2011 · AI
Genomic Studies - NIAID/DCR
$6,000,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Development of Adeno-Associated Virus for Delivery of VRC01
$6,000,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
DMID CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT
$6,000,000Melynda Holmes · Technical Resources International, Inc. · N01 · FY2010 · AI
Vaccine and Therapeutics Development:
$6,000,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
RII Track-2 FEC: Membrane Purification Platform for Continuous Biomanufacturing of Viral Vectors and Virus-like Particles in Arkansas and Beyond
$5,999,758Xianghong Qian · University Of Arkansas · · FY2022 · O/D
Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers
$5,997,620Erica Ollmann Saphire · Scripps Research Institute, The · U19 · FY2014 · AI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network
$5,995,463Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2013 · AI
Medical Oncology Fellowship Program
$5,992,340Antonio Fojo · Division Of Basic Sciences - Nci · ZIE · FY2009 · CA
The Identification of HLA class I and class II T cell epitopes from Dengue Virus
$5,982,817La Jolla Institute For Immunology · N01 · FY2009 · AI
Translational Immunology Core
$5,972,985Lisa Wagar · University Of California-Irvine · U19 · FY2024 · AI
Development and Production of SARS-CoV2 Biologicals and Vaccines
$5,963,191Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT
$5,962,573Medical Research Council Of South Africa · U01 · FY2005 · AI
Genetic variants associated with smallpox vaccine immune response heterogeneity
$5,959,137 · N01 · FY2010 · AI
Medical Oncology Fellowship Program
$5,952,865Antonio Fojo · Division Of Basic Sciences - Nci · ZIE · FY2010 · CA
Intervention Trials in Persons at Increased Genetic Risk of Cancer
$5,949,905Mark H Greene · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$5,928,118Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2025 · AI
SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens
$5,902,563Wilton B Williams · Duke University · UM1 · FY2023 · AI